CD40L, a costimulatory molecule present on T cells, was found to be released by activated platelets in the serum, that may contribute to pulmonary thrombotic complications observed in COVID-19 as well as being associated with ARDS status (67, 68). This evidence concerns the gene CD40LG and COVID-19.